Who Paid My Doc
Research study
Program year 2020
Source: CMS Open Payments
04-030# Captisol-Enabled Melphalan Stability Study
Research payments
$46,548
Through program year 2020, $46,548 in research payments was reported against 04-030# Captisol-Enabled Melphalan Stability Study, across 1 payment, paid by Aurobindo Pharma USA, Inc..
- Paid by
- Aurobindo Pharma USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $46,548 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.